TY - JOUR
T1 - Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance
T2 - Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II)
AU - Escaned, Javier
AU - Echavarría-Pinto, Mauro
AU - Garcia-Garcia, Hector M
AU - van de Hoef, Tim P
AU - de Vries, Ton
AU - Kaul, Prashant
AU - Raveendran, Ganesh
AU - Altman, John D
AU - Kurz, Howard I
AU - Brechtken, Johannes
AU - Tulli, Mark
AU - Von Birgelen, Clemens
AU - Schneider, Joel E
AU - Khashaba, Ahmed A
AU - Jeremias, Allen
AU - Baucum, Jim
AU - Moreno, Raul
AU - Meuwissen, Martijn
AU - Mishkel, Gregory
AU - van Geuns, Robert-Jan
AU - Levite, Howard
AU - Lopez-Palop, Ramon
AU - Mayhew, Marc
AU - Serruys, Patrick W
AU - Samady, Habib
AU - Piek, Jan J
AU - Lerman, Amir
N1 - Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
PY - 2015/5
Y1 - 2015/5
N2 - OBJECTIVES: The purpose of this study was to assess the diagnostic accuracy of the instantaneous wave-free ratio (iFR) to characterize, outside of a pre-specified range of values, stenosis severity, as defined by fractional flow reserve (FFR) ≤0.80, in a prospective, independent, controlled, core laboratory-based environment.BACKGROUND: Studies with methodological heterogeneity have reported some discrepancies in the classification agreement between iFR and FFR. The ADVISE II (ADenosine Vasodilator Independent Stenosis Evaluation II) study was designed to overcome limitations of previous iFR versus FFR comparisons.METHODS: A total of 919 intermediate coronary stenoses were investigated during baseline and hyperemia. From these, 690 pressure recordings (n = 598 patients) met core laboratory physiology criteria and are included in this report.RESULTS: The pre-specified iFR cut-off of 0.89 was optimal for the study and correctly classified 82.5% of the stenoses, with a sensitivity of 73.0% and specificity of 87.8% (C statistic: 0.90 [95% confidence interval (CI): 0.88 to 0.92, p < 0.001]). The proportion of stenoses properly classified by iFR outside of the pre-specified treatment (≤0.85) and deferral (≥0.94) values was 91.6% (95% CI: 88.8% to 93.9%). When combined with FFR use within these cut-offs, the percent of stenoses properly classified by such a pre-specified hybrid iFR-FFR approach was 94.2% (95% CI: 92.2% to 95.8%). The hybrid iFR-FFR approach obviated vasodilators from 65.1% (95% CI: 61.1% to 68.9%) of patients and 69.1% (95% CI: 65.5% to 72.6%) of stenoses.CONCLUSIONS: The ADVISE II study supports, on the basis rigorous methodology, the diagnostic value of iFR in establishing the functional significance of coronary stenoses, and highlights its complementariness with FFR when used in a hybrid iFR-FFR approach. (ADenosine Vasodilator Independent Stenosis Evaluation II-ADVISE II; NCT01740895).
AB - OBJECTIVES: The purpose of this study was to assess the diagnostic accuracy of the instantaneous wave-free ratio (iFR) to characterize, outside of a pre-specified range of values, stenosis severity, as defined by fractional flow reserve (FFR) ≤0.80, in a prospective, independent, controlled, core laboratory-based environment.BACKGROUND: Studies with methodological heterogeneity have reported some discrepancies in the classification agreement between iFR and FFR. The ADVISE II (ADenosine Vasodilator Independent Stenosis Evaluation II) study was designed to overcome limitations of previous iFR versus FFR comparisons.METHODS: A total of 919 intermediate coronary stenoses were investigated during baseline and hyperemia. From these, 690 pressure recordings (n = 598 patients) met core laboratory physiology criteria and are included in this report.RESULTS: The pre-specified iFR cut-off of 0.89 was optimal for the study and correctly classified 82.5% of the stenoses, with a sensitivity of 73.0% and specificity of 87.8% (C statistic: 0.90 [95% confidence interval (CI): 0.88 to 0.92, p < 0.001]). The proportion of stenoses properly classified by iFR outside of the pre-specified treatment (≤0.85) and deferral (≥0.94) values was 91.6% (95% CI: 88.8% to 93.9%). When combined with FFR use within these cut-offs, the percent of stenoses properly classified by such a pre-specified hybrid iFR-FFR approach was 94.2% (95% CI: 92.2% to 95.8%). The hybrid iFR-FFR approach obviated vasodilators from 65.1% (95% CI: 61.1% to 68.9%) of patients and 69.1% (95% CI: 65.5% to 72.6%) of stenoses.CONCLUSIONS: The ADVISE II study supports, on the basis rigorous methodology, the diagnostic value of iFR in establishing the functional significance of coronary stenoses, and highlights its complementariness with FFR when used in a hybrid iFR-FFR approach. (ADenosine Vasodilator Independent Stenosis Evaluation II-ADVISE II; NCT01740895).
KW - Adenosine/administration & dosage
KW - Aged
KW - Algorithms
KW - Cardiac Catheterization
KW - Coronary Angiography
KW - Coronary Stenosis/classification
KW - Electrocardiography
KW - Female
KW - Fractional Flow Reserve, Myocardial
KW - Hemodynamics
KW - Humans
KW - Hyperemia/physiopathology
KW - Male
KW - Middle Aged
KW - Predictive Value of Tests
KW - Prognosis
KW - Prospective Studies
KW - Reproducibility of Results
KW - Severity of Illness Index
KW - Signal Processing, Computer-Assisted
KW - Vasodilator Agents/administration & dosage
U2 - 10.1016/j.jcin.2015.01.029
DO - 10.1016/j.jcin.2015.01.029
M3 - Article
C2 - 25999106
SN - 1936-8798
VL - 8
SP - 824
EP - 833
JO - JACC. Cardiovascular Interventions
JF - JACC. Cardiovascular Interventions
IS - 6
ER -